Perceptive adds IBM software to support tech interoperability

24-Oct-2010 - Last updated on 25-Oct-2010 at 10:07 GMT

Perceptive Informatics has incorporated IBM software into its eClinical platform to support interoperability between clinical trial technologies.

Growth in the number of technologies used in clinical trials has increased complexity and created a need for tools to ensure interoperability and streamline workflows. To meet these needs Perceptive has incorporated WebSphere and Tivoli Access Manager into its eClinical suite.

Nicholas Richards, vice president, product development, Perceptive, said: "As the number of technologies used in clinical trials increases, Perceptive is committed to expanding our robust and flexible enterprise platform to meet customer demand.”

WebSphere portal framework from IBM provides centralised access to clinical trial documentation and training materials. Furthermore, the portal can be used to collaborate on the development of materials and discuss a study and its conduct with other users.

For instance, a sponsor and contract research organisation (CRO) can collaborate on the creation of study documentation, improving the workflow. Also, the system can be used to share best practices among the study community, including monitors and site personnel.

The portal features built-in data integration with Parexel tools, such as DataLabs and ClinPhone, and allows users to access and report data from third-party systems. Data from various sources is aggregated to support decision making at trial-, programme- and portfolio level.

Single sign-on

Incorporation of Tivoli Access Manager, also from IBM, improves single sign-on. Using the system eliminates the need for multiple user names and passwords by providing access to multiple tools using one login.

Both technologies also provide support for Software-as-a-Service (SaaS) applications of Perceptive’s eClinical suite.

“Our customers can benefit from foundational technologies that further enhance the capabilities of our eClinical Suite to bring more efficiency to biopharmaceutical development", said Richards.